A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID; ...

Researchers hoped results from the latest trial on low-dose lithium would settle the question of lithium’s potential to ...

BUFFALO, N.Y. — A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of ...

Low-dose lithium aspartate did not improve fatigue and cognitive dysfunction symptoms in long COVID. A small dose-finding study suggested higher doses might be effective, but a new trial is needed.

A once-daily dose of a medication, which averaged 195 mg, produced blood levels significantly lower than those typically pursued by psychiatrists. However, it succeeded in generating a weak signal ...

Findings seen in pilot study of older adults with mild cognitive impairment, but other coprimary outcomes did not meet significance thresholds. HealthDay News — Low‑dose oral lithium may slow verbal ...

Initial trials of low-dose lithium failed to improve long COVID symptoms, but new findings suggest higher doses could offer hope for patients suffering from fatigue and cognitive impairment. Study: ...

Dear Dr. Roach: Would it be risky to take a low dose (20 mg) of over-the-counter lithium orotate to treat cognitive decline? The recent study in the journal Nature recommended waiting for further ...

Q. My young adult daughter has been taking Zoloft for depression. She recently weaned off of it and her new doctor put her on 5 milligrams of lithium orotate. She first tried to take bupropion but ...

People with Alzheimer’s disease have lower levels of lithium in their brains, and giving lithium to mice with symptoms of the condition reverses cognitive decline. Together, the findings suggest that ...